The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Brain Research

• Publication date

  2003-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0006-8993(03)03444-9PMID 14568335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.

  2002cited by this paper
• Reduction of Stress-Induced Behavior by Antagonism of Corticotropin-Releasing Hormone 2 (CRH2) Receptors in Lateral Septum or CRH1 Receptors in Amygdala

  2002cited by this paper
• Modulation of melanocortin-induced changes in spinal nociception by &mgr;-opioid receptor agonist and antagonist in neuropathic rats

  2002cited by this paper
• Melanocortin receptors: their functions and regulation by physiological agonists and antagonists

  2001cited by this paper
• Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal

  2000cited by this paper
• The role of corticotropin‐releasing factor in pain and analgesia

  2000cited by this paper
• Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat.

  2000cited by this paper
• A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences

  2000cited by this paper
• Differential roles of corticotropin‐releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence

  2000cited by this paper
• Presence of mu-opioid receptors in targets of efferent projections from the central nucleus of the amygdala to the nucleus of the solitary tract.

  1999cited by this paper
• Presence of μ‐opioid receptors in targets of efferent projections from the central nucleus of the amygdala to the nucleus of the solitary tract

  1999cited by this paper
• Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.

  1998cited by this paper
• Melanocortins and opiate addiction.

  1997cited by this paper
• Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin.

  1996cited by this paper
• Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.

  1996cited by this paper
• Suppression of corticotropin‐releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

  1995cited by this paper
• Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

  1994cited by this paper
• Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.

  1992cited by this paper
• Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray.

  1990cited by this paper
• Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion.

  1986cited by this paper
• Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.

  1984cited by this paper
• Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The influence of neuropeptides related to pro-opiomelanocortin on acquisition of heroin self-administration of rats.

  1983cited by this paper
• Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologic specificity.

  1983cited by this paper
• The influence of neuropeptides related to pro-opiomelanocortin on acquisition of heroin self-administration of rats

  1983cited by this paper
• Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone(alpha-MSH).

  1979cited by this paper
• Effects of morphine and beta-endorphin on basal and elevated plasma levels of alpha-MSH and vasopressin.

  1979cited by this paper
• Attenuation of morphine tolerance and dependence by α-melanocyte stimulating hormone (α-MSH)

  1979cited by this paper
• Effects of morphine and β-endorphin on basal and elevated plasma levels of α-MSH and vasopressin

  1979cited by this paper
• Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats.

  1978cited by this paper
• beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

  1977cited by this paper
• MSH activity in plasma and pituitaries of rats after various treatments.

  1969cited by this paper

• Melanocortin-4 receptor signaling in the central amygdala mediates chronic inflammatory pain effects on nociception.

  2022cites this paper
• The Role of Melanocortin Plasticity in Pain-Related Outcomes After Alcohol Exposure

  2021cites this paper
• Forebrain-Midbrain Circuits and Peptides Involved in Hyperalgesia After Chronic Alcohol Exposure

  2021cites this paper
• Novel bifunctional hybrid compounds designed to enhance the effects of opioids and antagonize the pronociceptive effects of nonopioid peptides as potent analgesics in a rat model of neuropathic pain

  2020cites this paper
• Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse neuropathic pain model.

  2020cites this paper
• The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

  2019influential citation
• Bupropion, Alone and in Combination with Naltrexone, Blunts Binge‐Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice

  2019cites this paper
• The Role of the Melanocortin System in Drug and Alcohol Abuse.

  2017cites this paper
• Intra‐cerebral and intra‐nasal melanocortin‐4 receptor antagonist blocks withdrawal hyperalgesia in alcohol‐dependent rats

  2017influential citation
• Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

  2017cites this paper
• Nucleus Accumbens MC4-R Stimulation Reduces Food and Ethanol Intake in Adult Rats Regardless of Binge-Like Ethanol Exposure during Adolescence

  2017cites this paper
• Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

  2015cites this paper
• Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin.

  2015cites this paper
• Hypothalamic Pathophysiology in the Neuroimmune Dysmetabolic and Longevity Complications of Chronic Opiate Dependency

  2014cites this paper
• Blockage of melanocortin‐4 receptors by intranasal HS014 attenuates single prolonged stress‐triggered changes in several brain regions

  2014cites this paper
• CRH CRH CRH CRH CRH CRH CRH CRH CRH POMC POMC POMC LIMBIC HYPOTHALAMUS PITUITARY ACTH

  2013cites this paper
• Intrathecal Lamotrigine Attenuates Antinociceptive Morphine Tolerance and Suppresses Spinal Glial Cell Activation in Morphine-Tolerant Rats

  2013cites this paper
• Addiction and the adrenal cortex

  2013cites this paper
• Effect of periaqueductal gray melanocortin 4 receptor in pain facilitation and glial activation in rat model of chronic constriction injury

  2012cites this paper
• Hypothalamic opioid-melanocortin appetitive balance and addictive craving.

  2011cites this paper
• The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

  2011cites this paper
• The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

  2010cites this paper
• Distribution and function of melanocortin receptors within the brain.

  2010cites this paper
• Tianeptine reduces morphine antinociceptive tolerance and physical dependence

  2010cites this paper
• Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain — a biochemical and behavioral study

  2009cites this paper
• Intrathecal lamotrigine blocks and reverses antinociceptive morphine tolerance in rats.

  2009cites this paper
• Opioid and melanocortin receptors: Do they have overlapping pharmacophores?

  2008cites this paper
• Involvement of alpha-melanocyte stimulating hormone (alpha-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates.

  2008cites this paper
• Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.

  2007cites this paper
• Roles of acetylation and other post-translational modifications in melanocortin function and interactions with endorphins.

  2006cites this paper
• Inhibition of morphine tolerance by spinal melanocortin receptor blockade

  2005cites this paper
• Involvement of melanocortin-4 receptor in anxiety and depression.

  2005cites this paper
• Evidence for the involvement of MC4 receptors in the central mechanisms of opioid antinociception

  2005cites this paper
• Opioid abuse and brain gene expression.

  2004cites this paper
• Endogenous opiates and behavior: 2003.

  2004cites this paper